Structured Rehabilitation for Patients with Atrial Fibrillation Based on an Integrated Care Approach: Protocol for a Prospective, Observational Cohort Study

References

• Zhang J, Johnsen SP, Guo Y, et al. Epidemiology of atrial fibrillation: geographic/ecological risk factors, age, sex, genetics. Card Electrophysiol Clin. 2021;13(1):1–23. doi:10.1016/j.ccep.2020.10.010
   PubMedGoogle Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Vesa ŞC, Vlaicu SI, Sabin O, et al. Evaluating physician adherence to antithrombotic recommendations in patients with atrial fibrillation: a pathway to better medical education. Int J Environ Res Public Health. 2020;17(11):4008. doi:10.3390/ijerph17114008
   PubMed Web of Science ®Google Scholar
• Yao X, Shah ND, Sangaralingham LR, et al. Non-Vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. J Am Coll Cardiol. 2017;69(23):2779–2790. doi:10.1016/j.jacc.2017.03.600
   PubMed Web of Science ®Google Scholar
• Chan YH, Chao TF, Chen SW, et al. Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation. Heart Rhythm. 2020;17(12):2102–2110. doi:10.1016/j.hrthm.2020.07.022
   PubMed Web of Science ®Google Scholar
• Banerjee A, Benedetto V, Gichuru P, et al. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study. Heart. 2020;106(2):119–126. doi:10.1136/heartjnl-2019-315307
   PubMed Web of Science ®Google Scholar
• Nielsen-Kudsk JE, Korsholm K, Damgaard D, et al. Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation. JACC Cardiovasc Interv. 2021;14(1):69–78. doi:10.1016/j.jcin.2020.09.051
   PubMed Web of Science ®Google Scholar
• Krittayaphong R, Winijkul A, Kunjara-Na-Ayudhya R, et al. Adherence to anticoagulant guideline for atrial fibrillation improves outcomes in asian population: the COOL-AF registry. Stroke. 2020;51(6):1772–1780. doi:10.1161/strokeaha.120
   PubMed Web of Science ®Google Scholar
• Working Group on Atrial Fibrillation NCfCQI. 2019 clinical performance and quality measures for atrial fibrillation in China. Chin Circul J. 2020;35(5):427–437.
   Google Scholar
• Chen Y, Huang QF, Sheng CS, et al. Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): a prospective multicenter study. PLoS Med. 2020;17(7):e1003146. doi:10.1371/journal.pmed.1003146
   PubMed Web of Science ®Google Scholar
• Guo Y, Lane DA, Chen Y, et al. Regular bleeding risk assessment associated with reduction in bleeding outcomes: the mAFA-II randomized trial. Am J Med. 2020;133(10):1195–202.e2. doi:10.1016/j.amjmed.2020.03.019
   PubMed Web of Science ®Google Scholar
• Guo Y, Lane DA, Wang L, et al. Mobile health technology to improve care for patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(13):1523–1534. doi:10.1016/j.jacc.2020.01.052
   PubMed Web of Science ®Google Scholar
• Guo Y, Guo J, Shi X, et al. Mobile health technology-supported atrial fibrillation screening and integrated care: a report from the mAFA-II trial Long-term Extension Cohort. Eur J Intern Med. 2020;82:105–111. doi:10.1016/j.ejim.2020.09.024
   PubMed Web of Science ®Google Scholar
• Varma N, Cygankiewicz I, Turakhia MP, et al. 2021 ISHNE/HRS/EHRA/APHRS expert collaborative statement on mhealth in arrhythmia management: digital medical tools for heart rhythm professionals: from the international Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society. Circ Arrhythm Electrophysiol. 2021:Circep120009204. doi:10.1161/circep.120.009204
   Web of Science ®Google Scholar
• Varma N, Marrouche NF, Aguinaga L, et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic. Europace. 2021;23(2):313. doi:10.1093/europace/euaa187
   PubMed Web of Science ®Google Scholar
• Kozieł M, Simovic S, Pavlovic N, et al. Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the Balkan-AF survey. Ann Med. 2021;53(1):17–25. doi:10.1080/07853890.2020.1799241
   PubMed Web of Science ®Google Scholar
• Lip GYH, Tran G, Genaidy A, et al. Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co-morbidity profiles/multi-morbidity in a large US adult cohort. Int J Clin Pract. 2021;75:e14042. doi:10.1111/ijcp.14042
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Y, Lane DA, et al. Mobile health technology for atrial fibrillation management integrating decision support, education, and Patient Involvement: mAF app trial. Am J Med. 2017;130(12):1388–96.e6. doi:10.1016/j.amjmed.2017.07.003
   PubMed Web of Science ®Google Scholar
• Guo Y, Lane DA, Wang L, et al. Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: the mAFA (mAF-App) II randomised trial. Int J Clin Pract. 2019;73(7):e13352. doi:10.1111/ijcp.13352
   PubMed Web of Science ®Google Scholar
• Domek M, Gumprecht J, Li YG, et al. Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the middle east based on the gulf SAFE registry. Eur J Clin Invest. 2020;51:e13385. doi:10.1111/eci.13385
   PubMed Web of Science ®Google Scholar
• Gumprecht J, Domek M, Proietti M, et al. Compliance of atrial fibrillation treatment with the atrial fibrillation better care (ABC) pathway improves the clinical outcomes in the middle east population: a report from the gulf survey of atrial fibrillation events (SAFE) registry. J Clin Med. 2020;9(5):1286. doi:10.3390/jcm9051286
   PubMed Web of Science ®Google Scholar
• Ferrat E, Fabre J, Galletout P, et al. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care. Br J Gen Pract. 2021;71(703):e134–e39. doi:10.3399/bjgp20X714005
   PubMed Web of Science ®Google Scholar
• Feng Y, Pai CW, Seiler K, et al. Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study. J Thromb Thrombolysis. 2021;51:1144–1149. doi:10.1007/s11239-020-02358-3
   PubMed Web of Science ®Google Scholar